The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...

Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's drug pipeline, vaccines and more.

Pfizer Inc. is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the ...

The president has said the law is unfair to U.S. businesses. But lawyers say weakening it could end up costing corporate ...

Trump administration to eliminate thousands of federal health jobs; Major drugmakers plan to meet with Trump; New York versus Louisiana abortion pills fight.

Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS Secretary.

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...

We ranked the 10 best commercials from the 2025 Super Bowl and found them online so you can judge them for yourself.

Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even more ...